Ceapro

About:

Ceapro is into developing functionally active ingredients derived from oats and renewable plant resources for healthcare and cosmetic needs.

Website: http://ceapro.com/

Twitter/X: CeaproInc

Top Investors: National Research Council Canada, National Research Council of Canada Industrial Research Assistance Program, Natural Sciences and Engineering Research Council of Canada (NSERC), Canadian Institutes of Health Research

Description:

Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and "active ingredients" from oats and other renewable plant resources. Ceapro adds further value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The Company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions.

Total Funding Amount:

$1.74M

Headquarters Location:

Edmonton, Alberta, Canada

Founded Date:

1997-01-01

Contact Email:

info(AT)ceapro.com

Founders:

Jean-Guy Boulet

Number of Employees:

11-50

Last Funding Date:

2021-11-29

IPO Status:

Public

Industries:

© 2025 bioDAO.ai